Weihu Wang

4.9k total citations
210 papers, 3.1k citations indexed

About

Weihu Wang is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Weihu Wang has authored 210 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Oncology, 80 papers in Surgery and 61 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Weihu Wang's work include Colorectal Cancer Surgical Treatments (41 papers), Colorectal and Anal Carcinomas (38 papers) and Lymphoma Diagnosis and Treatment (36 papers). Weihu Wang is often cited by papers focused on Colorectal Cancer Surgical Treatments (41 papers), Colorectal and Anal Carcinomas (38 papers) and Lymphoma Diagnosis and Treatment (36 papers). Weihu Wang collaborates with scholars based in China, United States and Ethiopia. Weihu Wang's co-authors include Ye‐Xiong Li, Shulian Wang, Yue‐Ping Liu, Zihao Yu, Xin-Fan Liu, Jing Jin, Hui Fang, Yong-Wen Song, Liqiang Zhou and Yueping Liu and has published in prestigious journals such as Cell, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Weihu Wang

191 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weihu Wang China 29 1.5k 1.2k 859 547 439 210 3.1k
Ye‐Xiong Li China 34 2.1k 1.4× 1.9k 1.6× 972 1.1× 893 1.6× 231 0.5× 283 4.5k
Roland S. Croner Germany 31 1.5k 1.0× 440 0.4× 1.1k 1.3× 852 1.6× 346 0.8× 230 3.7k
S. Meijer Netherlands 34 1.3k 0.9× 696 0.6× 1.5k 1.7× 1.1k 2.1× 212 0.5× 87 3.7k
Karin A. Oien United Kingdom 31 2.1k 1.3× 555 0.5× 561 0.7× 496 0.9× 186 0.4× 64 3.6k
Marie-Danièle Diébold France 21 1.2k 0.8× 530 0.5× 383 0.4× 514 0.9× 346 0.8× 47 2.4k
Soomin Ahn South Korea 27 1.2k 0.8× 377 0.3× 513 0.6× 647 1.2× 185 0.4× 132 2.6k
Yong Beom Cho South Korea 41 3.2k 2.1× 612 0.5× 2.5k 2.9× 1.0k 1.8× 677 1.5× 288 5.7k
Sang Yun Ha South Korea 28 1.2k 0.8× 347 0.3× 661 0.8× 890 1.6× 786 1.8× 155 3.2k
Heounjeong Go South Korea 30 1.8k 1.2× 601 0.5× 451 0.5× 1.5k 2.8× 121 0.3× 126 3.6k
Giuseppe Perrone Italy 27 1.2k 0.8× 359 0.3× 531 0.6× 536 1.0× 145 0.3× 122 2.6k

Countries citing papers authored by Weihu Wang

Since Specialization
Citations

This map shows the geographic impact of Weihu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weihu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weihu Wang more than expected).

Fields of papers citing papers by Weihu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weihu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weihu Wang. The network helps show where Weihu Wang may publish in the future.

Co-authorship network of co-authors of Weihu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Weihu Wang. A scholar is included among the top collaborators of Weihu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weihu Wang. Weihu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Teng, Yue, Dapeng Ma, Yan Yan, et al.. (2024). Retrospective cohort study for thrombocytopenia during concurrent chemoradiotherapy for rectal cancer. Frontiers in Oncology. 13. 1289824–1289824. 1 indexed citations
2.
Wang, Weihu, et al.. (2024). Safety and efficacy of camrelizumab and apatinib in combination with IMRT in unresectable hepatocellular carcinoma: A non-randomised phase 2 study.. Journal of Clinical Oncology. 42(16_suppl). e16157–e16157. 1 indexed citations
3.
Xu, Fang, et al.. (2024). Improving routing performance in social internet of things with FNRA: The free node-based approach. Alexandria Engineering Journal. 88. 68–79. 5 indexed citations
4.
Cui, Yujun, Shuai Li, Hongzhi Wang, et al.. (2024). Clinicopathological factors predict residual lymph node metastasis in locally advanced rectal cancer with ypT0-2 after neoadjuvant chemoradiotherapy. Journal of Cancer Research and Clinical Oncology. 150(4). 176–176. 2 indexed citations
5.
Cui, Yujun, Xinzhi Liu, Shuai Li, et al.. (2023). The ypT may better predict the efficacy of neoadjuvant chemoradiotherapy than tumor regression grade in locally advanced rectal cancer patients diagnosed ypT1-4N0. Clinical & Translational Oncology. 26(4). 1012–1021. 3 indexed citations
6.
Wang, Hongzhi, Xuan Zheng, Jiawen Sun, et al.. (2023). 4D-MRI assisted stereotactic body radiation therapy for unresectable colorectal cancer liver metastases. Clinical and Translational Radiation Oncology. 45. 100714–100714. 2 indexed citations
7.
8.
9.
Dong, Dezuo, Xianggao Zhu, Hongzhi Wang, et al.. (2022). Prognostic significance of albumin–bilirubin score in patients with unresectable hepatocellular carcinoma undergoing combined immunotherapy and radiotherapy. Journal of Medical Imaging and Radiation Oncology. 66(5). 662–670. 7 indexed citations
10.
Li, Shuai, Hongzhi Wang, Ke Hu, et al.. (2022). MRI radiomics independent of clinical baseline characteristics and neoadjuvant treatment modalities predicts response to neoadjuvant therapy in rectal cancer. British Journal of Cancer. 127(2). 249–257. 31 indexed citations
11.
Wang, Hongzhi, Xianggao Zhu, Yuting Zhao, et al.. (2022). Phase 1 trial of apatinib combined with intensity-modulated radiotherapy in unresectable hepatocellular carcinoma. BMC Cancer. 22(1). 2 indexed citations
12.
Li, Shuai, Yangzi Zhang, Jianhao Geng, et al.. (2021). Is Elective Inguinal or External Iliac Irradiation During Neoadjuvant (Chemo)radiotherapy Necessary for Locally Advanced Lower Rectal Cancer With Anal Sphincter Invasion?. Practical Radiation Oncology. 12(2). 125–134. 4 indexed citations
13.
Zhao, Yang, Rong Yu, Wei Deng, & Weihu Wang. (2021). Genetic evidence for the causal association between programmed death-ligand 1 and lung cancer. Journal of Cancer Research and Clinical Oncology. 147(11). 3279–3288. 2 indexed citations
14.
Chen, Bo, Jianxiong Wu, Liming Wang, et al.. (2021). Phase 2 Study of Adjuvant Radiotherapy Following Narrow‐Margin Hepatectomy in Patients With HCC. Hepatology. 74(5). 2595–2604. 48 indexed citations
15.
Dong, Dezuo, Weimin Zhang, Qingnan Wu, et al.. (2020). A GRN Autocrine-Dependent FAM135B/AKT/mTOR Feedforward Loop Promotes Esophageal Squamous Cell Carcinoma Progression. Cancer Research. 81(4). 910–922. 24 indexed citations
16.
Wang, Yujie, Qian Lü, Lichuan Zhang, et al.. (2020). Nutrition Impact Symptom Clusters in Patients With Head and Neck Cancer Receiving Concurrent Chemoradiotherapy. Journal of Pain and Symptom Management. 62(2). 277–285. 18 indexed citations
17.
18.
Wang, Xin, Jing Jin, Ye‐Xiong Li, et al.. (2011). Analysis of recurrence for locally advanced gastric or gastroesophageal cancer patients after receiving curative gastrectomy ( ＞ D1 ) and its indication for adjuvant chemoradiotherapy. Zhonghua fangshe zhongliuxue zazhi. 20(2). 133–137. 3 indexed citations
19.
Li, Ye‐Xiong, Hui Fang, Shunan Qi, et al.. (2009). Variable Clinical Presentations of Nasal and Waldeyer Ring Natural Killer/T-Cell Lymphoma. Clinical Cancer Research. 15(8). 2905–2912. 85 indexed citations
20.
Wang, Weihu, et al.. (2006). Radiation enhancement on fibrosarcoma cells by arsenic trioxide. Zhonghua fangshe zhongliuxue zazhi. 15(6). 448–451. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ye‐Xiong Li Breakdown of academic impact, for papers by Roland S. Croner Breakdown of academic impact, for papers by S. Meijer Breakdown of academic impact, for papers by Karin A. Oien Breakdown of academic impact, for papers by Marie-Danièle Diébold Breakdown of academic impact, for papers by Soomin Ahn Breakdown of academic impact, for papers by Yong Beom Cho Breakdown of academic impact, for papers by Sang Yun Ha Breakdown of academic impact, for papers by Heounjeong Go Breakdown of academic impact, for papers by Giuseppe Perrone
Rankless by CCL
2026